Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Glycan Therapeutics

+1 (919) 977-1083
Website

Advertisement

Advertisement

617 Hutton St Ste 101
Raleigh, NC 27606
+1 (919) 977-1083
https://www.glycantherapeutics.com

Glycan Therapeutics is a biotechnology company based in Raleigh, NC, specializing in the research and development of innovative therapeutic solutions.

With a focus on glycan-based technologies, the company aims to address unmet medical needs and improve patient outcomes through cutting-edge scientific advancements.

Generated from their business information

Also at this address

Protochips Inc

Array Xpress

1st Source Research Inc

Celplor

Own this business?
Claim it
See a problem?

You might also like

Drugs and drug proprietaries, Drugs acting on the respiratory system, Blood derivatives

Grifols Therapeutics LLC

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatment for people with life-threatening disorders. The company s wholly owned subsidiary, Talecris Plasma Resources, is a national network of plasma collection centers that provides the source material for the production of critical care protein therapies. Talecris Biotherapeutics employs more than 4,300 people worldwide. The company is licensed to do in-house nucleic acid testing for hepatitis C, hepatitis B and human immunodeficiency virus. It offers aseptic filling, plasma fractionation and pharmaceutical compounding, as well as extraction, concentration and purification services for complex molecules. Talecris Biotherapeutics sponsors external research grant programs.
Drugs acting on the respiratory system, Drugs and drug proprietaries

Chiesi USA, Inc

Critical Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The company owns rights to the asthma drug ZYFLO, or zileuton tablets, in addition to other formulations of zileuton throughout the world. ZYFLO is one of the only five lipoxygenase inhibitors approved for marketing by the Untied States Food and Drug Administration and is indicated for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. Critical Therapeutics s commercialization effort for ZYFLO is done with nearly 80 people on the company s specialty sales force. Headquartered in Lexington, Mass., Critical Therapeutics is a privately owned company.
Business services, nec, nec, Services, nec, nec, Surgical instruments and apparatus

Mycovia Pharmaceuticals

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.
United States›North Carolina›Raleigh›Glycan Therapeutics

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell